Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
China · Delayed Price · Currency is CNY 20.87
+0.19 (0.92%)
Feb 4, 2026, 3:00 PM CST
SHA:603538 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 99.48 | 66.81 | 11.59 | 338.86 | 142.53 | 155.96 |
Depreciation & Amortization | 133.03 | 133.03 | 118.48 | 101.76 | 98.94 | 87.54 |
Other Amortization | 4.59 | 4.59 | 7.66 | 7.5 | 4.82 | 3.07 |
Loss (Gain) From Sale of Assets | 1.08 | 1.08 | -17.51 | 20.31 | 6.17 | 2.14 |
Asset Writedown & Restructuring Costs | - | - | - | - | - | -56.87 |
Loss (Gain) From Sale of Investments | -4.84 | -4.84 | 0.57 | -183.39 | -21.11 | -21.83 |
Provision & Write-off of Bad Debts | 0.76 | 0.76 | 6.12 | -0.7 | 2.66 | -0.83 |
Other Operating Activities | -1.32 | 71.42 | 66.39 | 53.08 | 36.03 | 61.35 |
Change in Accounts Receivable | -91.69 | -91.69 | -98.84 | -213.63 | -50.86 | -28.23 |
Change in Inventory | -185.43 | -185.43 | -49.56 | -182.99 | -124.68 | -82.3 |
Change in Accounts Payable | 67.15 | 67.15 | -51.17 | 351.4 | 134.36 | 63.34 |
Change in Other Net Operating Assets | 24.9 | 24.9 | 24.33 | 24.96 | 12.77 | 26.36 |
Operating Cash Flow | 57.47 | 97.54 | 9.13 | 276.95 | 220.63 | 228.06 |
Operating Cash Flow Growth | -70.81% | 967.95% | -96.70% | 25.53% | -3.26% | 26.87% |
Capital Expenditures | -130.81 | -179.4 | -219.54 | -571.62 | -529.89 | -316.21 |
Sale of Property, Plant & Equipment | 2.25 | 2.17 | 0.18 | 3.38 | 2.13 | 0.48 |
Cash Acquisitions | - | - | - | - | -47.1 | - |
Divestitures | - | - | 109.96 | 487.93 | - | - |
Investment in Securities | 69.09 | 72.99 | -222.74 | 181.48 | -90.25 | -182.97 |
Other Investing Activities | -3.56 | 4.46 | 8.54 | -50.92 | 61.86 | 15.26 |
Investing Cash Flow | -63.02 | -99.79 | -323.61 | 50.26 | -603.25 | -483.44 |
Short-Term Debt Issued | - | - | - | - | - | 32.23 |
Long-Term Debt Issued | - | 717.52 | 708.32 | 769.02 | 847.8 | 1,006 |
Total Debt Issued | 796.62 | 717.52 | 708.32 | 769.02 | 847.8 | 1,039 |
Long-Term Debt Repaid | - | -709.54 | -620.47 | -753.93 | -793.74 | -812.66 |
Total Debt Repaid | -783.67 | -709.54 | -620.47 | -753.93 | -793.74 | -812.66 |
Net Debt Issued (Repaid) | 12.95 | 7.98 | 87.85 | 15.08 | 54.07 | 225.92 |
Issuance of Common Stock | 26.98 | 35.58 | 2.75 | 4.46 | 27.87 | - |
Repurchase of Common Stock | -0.63 | -0.63 | -1.12 | -0.1 | -0.17 | -0.53 |
Common Dividends Paid | -36.69 | -22.71 | -59.24 | -50.03 | -13.83 | -41.5 |
Other Financing Activities | 10.74 | 12.16 | 24.63 | -147.87 | 515.22 | -17.39 |
Financing Cash Flow | 13.35 | 32.39 | 54.87 | -178.46 | 583.15 | 166.5 |
Foreign Exchange Rate Adjustments | 11.87 | 8.84 | -3.45 | 14.63 | -2.29 | -2.04 |
Net Cash Flow | 19.66 | 38.98 | -263.06 | 163.39 | 198.23 | -90.92 |
Free Cash Flow | -73.34 | -81.87 | -210.41 | -294.67 | -309.26 | -88.16 |
Free Cash Flow Margin | -4.76% | -5.96% | -17.30% | -20.22% | -24.58% | -7.39% |
Free Cash Flow Per Share | -0.33 | -0.38 | -0.91 | -1.30 | -1.45 | -0.43 |
Cash Income Tax Paid | - | -8.63 | 55 | 35.09 | -48.68 | -24.6 |
Levered Free Cash Flow | -71.26 | -124.44 | -254.43 | -78.85 | -296.94 | -176.41 |
Unlevered Free Cash Flow | -29.57 | -94.27 | -236.27 | -61.69 | -280.02 | -161.54 |
Change in Working Capital | -175.31 | -175.31 | -184.16 | -60.48 | -49.41 | -2.47 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.